Abbott Laboratories | 8-K: Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance
Abbott Laboratories | 8-K: Current report
Abbott Laboratories | 8-K: Current report
Abbott Laboratories | 8-K: Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Abbott Laboratories | DEF 14A: Definitive information statements
Abbott Laboratories | DEFA14A: Others
Abbott Laboratories | 8-K: Current report
Abbott Laboratories | 8-K: Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
Abbott Laboratories | 8-K: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
Abbott Laboratories | 8-K/A: Current report (Amendment)
Abbott Laboratories | 8-K: Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
Abbott Laboratories | 8-K: Current report
Abbott Laboratories | 8-K/A: Current report (Amendment)
Abbott Laboratories | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Abbott Laboratories | 8-K: Current report
Abbott Laboratories | 8-K: Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
Abbott Laboratories | DEFA14A: Others
Abbott Laboratories | DEF 14A: Definitive proxy statements
Abbott Laboratories | 8-K: Current report
Abbott Laboratories | 8-K: Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook
No Data